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Abstract 
Biotin is an essential vitamin in plants and mammals functioning as the carbon dioxide carrier 
within central lipid metabolism. Bacterial pimeloyl-CoA synthetase (BioW) acts as a highly 
specific substrate selection gate ensuring the integrity of the carbon chain in biotin synthesis. 
BioW catalyses the condensation of pimelic acid (C7 dicarboxylic acid) with CoASH in an 
ATP dependent manner to form pimeloyl-CoA, the first dedicated biotin building block. 
Multiple structures of Bacillus subtilis BioW together capture all three substrates as well as 
the intermediate pimeloyl-adenylate and product pyrophosphate (PP i), and indicates that the 
enzyme uses an internal ruler to select the correct dicarboxylic acid substrate. Both the 
catalytic mechanism and the surprising stability of the adenylate intermediate were 
rationalized through site-directed mutagenesis. Building on this understanding, BioW was 
engineered to synthesise high value heptanoyl (C7) and octanoyl (C8) mono carboxylic acid-
CoA and C8 dicarboxylic-CoA products, highlighting the enzyme’s synthetic potential. 
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INTRODUCTION 
In fatty acid biosynthesis biotin is an essential carbon dioxide carrier cofactor within large 
enzyme complexes, such as acetyl-CoA carboxylase (ACC), that catalyse carboxylation of 
acetyl-CoA to form malonyl-CoA 1. Biotin (Fig. 1a) possesses two fused rings (ureido and 
thiophane) whose carbon skeleton derives from the unusual C7 α,ω-dicarboxylic acid, 
pimelic acid (1). Pioneering studies identified the intermediates involved in forming the fused 
bicyclic structure that have been shown to be conserved in all bacterial species 2-5. E. coli has 
proved a useful model organism to study biotin biosynthesis and sequencing of the genomic 
locus, the “bio operon”, revealed five genes (bioA, bioB, bioF, bioC and bioD) involved in 
biotin formation 6. Four of the five genes encode highly conserved enzymes that catalyse the 
conversion of pimeloyl-CoA to biotin (8-amino-7-oxononanoate synthase (AONS, bioF gene 
product), diaminononanoate synthase (DANS, bioA gene product), dethiobiotin synthetase 
(DTBS, bioD gene product) and biotin synthase (BS, bioB gene product, Fig. 1a) 7. The x-ray 
structures and catalytic mechanisms of the E. coli AONS, DANS, DTBS and BS enzymes 
have been reported 8-13.  
In contrast to the early biosynthetic steps, the origin of pimelic acid varies across bacterial 
species, and has been found in various forms: as a free di-acid, a mono-methyl ester, and 
transformed into a pimeloyl thioester by attachment to either coenzyme A (CoASH) or an 
acyl carrier protein (ACP) 14. The thioester is condensed with L-alanine in an AONS-
catalysed reaction to begin the late stages of biotin biosynthesis 8, 13. Labelling studies using 
13C acetate provided insight into the origin of the carbon atoms of pimeloyl-CoA and biotin 
in E. coli 15, 16. Two enzymes from the biotin pathway, BioC (a SAM-dependent 
methyltransferase) and BioH (an esterase), hijack fatty acid biosynthesis by methylating 
malonyl-ACP, then extending it through two rounds of the fatty acid synthase cycle 17. The 
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crystal structure of an inactive BioH S82A mutant:pimeloyl-ACP methyl ester complex 
revealed the origin of the acyl-chain length specificity 18.  
In Bacillus subtilis, the presence of genes encoding BioI and BioW enzymes has suggested 
that this microbe makes and processes the pimelic acid precursor differently from E. coli 19. 
BioI shows homology to cytochrome P450 enzymes but is able to complement biotin 
production in bioC or bioH mutant E. coli strains. Subsequently, crystal structures of BioI 
captured in complex with acyl-ACPs of varying chain lengths have provided a mechanistic 
understanding of how heme chemistry is used to act upon the acyl chain and generate pimelic 
acid 20, 21. BioW from Bacillus sphaericus has been characterised to have pimeloyl-CoA 
synthetase activity (EC number 6.2.1.14) 22, 23. This homolog displays high sequence identity 
to the predicted enzyme in B. subtilis so it is somewhat surprising that this enzyme was not 
characterised until recently 24. BioW uses pimelic acid and MgATP to generate a pimeloyl-
adenylate intermediate which subsequently reacts with CoASH to give the acyl-CoA thioester 
product (Fig. 1a). The BioW reaction is highly specific to pimelic acid; mono- and di-acids 
of different chain lengths are either not processed at all or are hydrolysed at the acyl-
adenylate stage in a proofreading manner 24. Whilst this ensures that only the correct vitamin 
is made in vivo rather than potentially toxic analogues with shorter and/or longer chains, it 
represents an unfortunate limitation for biotechnological applications. It also suggests that 
BioW has been under great selective pressure to accept only pimelic acid, since biotin 
vitamers with different chain lengths have never been isolated. 
The activation of carboxylic acids as adenylates is a common strategy in nature and 
exemplified in the ANL superfamily of adenylating enzymes that includes the acyl-CoA 
synthetases 25, 26. The carboxylate of biotin is also adenylated by a biotin protein ligase (BPL) 
for final transfer to the lysine side chain of carboxylases 27. The mechanism involves the 
attack of the carboxylate at the α-phosphate of ATP to form the adenylate, driven by 
4 
 
pyrophosphate (PP i) elimination (Fig. 1a). The proposed transition state is the negatively 
charged, penta-coordinate trigonal bipyramidal phosphorous atom, which is common to other 
triphosphate nucleotide utilising enzymes including kinases and DNA polymerases 26. 
Interestingly a structural link between kinases and one type of adenylase has been identified 
28. Sequence analysis of the B. subtilis BioW showed no homology with other known 
adenylases or ATP-dependent synthetases, suggesting it may represent another member of the 
adenylase enzyme superfamily.  
Here we present structural and mechanistic studies of B. subtilis BioW and reveal that it 
extends the number of folds capable of catalysing adenylation. It is the C-terminal domain 
that recognises pimelic acid with exquisite specificity, thus controlling entry into the biotin 
biosynthetic pathway. Structure-guided mutagenesis was used to generate an enzyme that can 
processes a range of fatty acid substrates, unlocking the synthetic potential of this enzyme for 
the production of acyl-CoAs. The ability to generate acyl-CoA thioesters through biocatalytic 
methods would be extremely valuable since they are used as substrates in studies of important 
metabolic enzymes such as those involved in fatty acid biosynthesis 29.  
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RESULTS 
B. subtilis BioW isolation and assay 
In contrast to previous studies 24 we found that a 6xHis-tag positioned at the N-terminus of B. 
subtilis BioW (Supplementary Results, Supplementary Fig. 1a, b and c), allowed the 
isolation of milligram amounts of active enzyme. By HPLC and mass spectrometry 
(Supplementary Fig. 2) we confirmed that BioW converted pimelic acid (C7 dicarboxylic 
acid, 1), MgATP and CoASH to pimeloyl-CoA (2), eluting at 16.2 minutes, with a mass of 
910.1865 Da (M+H+, expected 910.1855 for C28H46N7O19P 3S) and AMP. For all 
crystallisation, native mass spectrometry and substrate specificity assays the His-tag was 
removed and the resultant enzyme was a homodimer (Supplementary Fig. 1c). 
For enzyme kinetics we modified a commercially-available (ENZCHECK), coupled assay 
(pyrophosphatase (PPase), purine nucleoside phosphorylase (PNP)) which links PP i 
formation in the first half of the reaction to the formation of a colorimetric product detectable 
at 360 nm (Supplementary Fig. 3 30, 31). We also monitored acyl-CoA thioester bond 
formation at 230 nm 23 and observed pimeloyl-CoA (2) product formation by HPLC and mass 
spectrometry. The coupled assay proved to be more useful than the 230 nm assay due to 
lower background absorbance. We used the coupled assay to determine the kinetic 
parameters for the BioW substrates pimelic acid (Km = 70.5 ± 6.8 µM; k cat  = 0.48 ± 0.02 s-1) 
and ATP (299.6 ± 37.6 µM, k cat  = 0.44 ± 0.03 s-1) and the 230 nm assay used to measure the 
value for CoASH (229.3 ± 25.4 µM, k cat  = 0.87 ± 0.05 s-1) (Supplementary Fig. 4, 
Supplementary Table 1). We observed substantially higher enzyme activity than previously 
reported for pimelic acid (~0.480 s-1 compared with 8.4 × 10-5 s-1) 24 and our results are 
comparable with that observed for the B. sphaericus BioW; Km pimelate (145 µM), ATP 
(170 µM), CoASH (33 µM) and a k cat  of 0.4 s-1 23. We also used the coupled assay to 
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determine relative activities (based on the k cat) of dicarboxylic acid substrates of various 
carbon chain lengths (C5, glutaric acid (3); C6, adipic acid (4); C8, suberic acid (5); C9, 
azelaic acid (6)). This confirmed that the wild-type enzyme is highly specific for the native 
substrate since the k cat  values (0.0051 s-1 for 3, 0.0066 s-1 for 4, 0.0038 s-1 for 5 and 0.0001 s-1 
for 6) were all ≤1% compared with pimelic acid (0.480 s-1) (Fig. 1b and Supplementary 
Table 2). Importantly, very little activity (with large errors) was detected with both the 
monocarboxylate substrates heptanoic acid (7, 0.0016 s-1) and octanoic acid (8, 0.0020 s-1) 
with wild-type BioW (Fig. 1b and Supplementary Table 2). 
 
Structural analysis of BioW 
The asymmetric unit of BioW is a homodimer (Fig. 2a), and analysis with the PISA server 32 
identified that the observed dimer is stable, burying approximately 900 Å2 of surface area per 
monomer. The crystal structure was consistent with native mass spectrometry and gel 
filtration experiments. Each monomer consists of two domains, a small 70 residue N-terminal 
domain and a larger C-terminal domain (Fig. 2b). The N-terminal domain has a three-
stranded anti-parallel β-sheet (β1-3) with an α-helix lying on one face. The dimer interface is 
confined to the N-terminal domain that brings together the β3 strands of each monomer such 
that the dimer has a 6 stranded antiparallel β-sheet. In addition to these main chain hydrogen 
bonds, there are a few additional polar and hydrophobic interactions that involve the α-helix 
(α1). Superimposing monomers reveals that the relative orientation of domains differs within 
each monomer, suggesting the linkage between the domains is flexible. The C-terminal 
domain has a central, predominantly anti-parallel seven-stranded β-sheet; each face of the 
sheet has two α-helices and one of the helices (α5) stacks against a small two stranded 
parallel β-sheet (β4 and 13) (Fig. 2b). The domain has a fifth helix (α4) that packs against 
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the loop of the C-terminus. Analysis with PDB fold does not identify other enzymes with this 
fold, suggesting the structure represents an extension to the ANL family of enzymes known 
to catalyse the adenylation reaction 26. This family currently contains three classes (I-III) and 
so we propose BioW as the first representative of class IV. 
Two co-complexes, pimeloyl-adenylate plus PPi (Fig. 2c and Supplementary Fig. 5a) and 
AMP-PNP plus pimelic acid (Supplementary Fig. 5b and 5c) localize the active site almost 
entirely within the C-terminal domain and identify the residues in contact with ATP and 
pimelic acid. Although the AMP-PNP could be expected to be active (since the enzyme 
breaks the α-β not the β-γ bond) the inactivity of this derivative has been observed before 33. 
In both complexes the adenosine and ribose rings, the β and γ phosphates and the two Mg2+ 
ions are located in essentially identical positions making the same contacts with the protein 
(Fig. 2d and 2e  and Supplementary Fig. 5a, 5b, 5d and 5e). The adenosine ring sits in a 
pocket with the side chain of Arg145 stacking on its face; the ring itself makes two hydrogen 
bonds to the main chain at Val146, a hydrogen bond to Glu31 and to a network of water 
molecules. The ribose ring hydrogen bonds to Arg227, the main chain of Val122 and to the 
network of water molecules. Comparing the atoms at the α phosphate in both complexes 
reveals that the phosphorous atom has shifted less than 1.0 Å and the three oxygen atoms that 
remain are unaffected by bond breaking/making and have shifted less than 0.2 Å. Two of 
these oxygen atoms are each bound to a different Mg2+ ion, the third oxygen atom which 
connects to the ribose ring is salt bridged to Arg227. 
Combining the complexes reveals that the α oxygen-phosphorous bond which connects to the 
β-phosphate makes an angle of 180° with the oxygen atom that links the α phosphorous to 
the carboxylate of pimelic acid (Fig. 2d). From these structures, a model of the penta-
covalent bipyramidal transition state can be constructed. The carboxyl-adenylate bond sits 
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between Ser194 on one side and on the other side two water molecules (denoted W1 and W2) 
which are hydrogen bonded to each other (Fig. 2e). The Ser194 side chain is hydrogen 
bonded to the protein main chain. The hydrogen bond network of these water molecules is 
extensive but neither is ideally positioned to attack the carbonyl. W1 is bound to the guanidyl 
group of Arg227, which would be predicted to lower the nucleophilicity of the water, whilst 
W2 is hydrogen-bonded to W1 and would require some re-arrangement to be correctly 
positioned for attack. In the adenylate complex Arg170 is hydrogen bonded to the pimelic 
acid carboxylate oxygen atom that is not linked to the phosphorous. In contrast, in the 
enzyme complex with AMP-PNP and pimelic acid, the carboxylate group is in a different 
orientation and not aligned for attack at the α phosphate (Supplementary Fig. 5b). The 
carboxylate makes a different salt bridge to Arg170 and hydrogen bonds to Ser194 as well as 
water molecules ligated to the Mg2+ ions. The β and γ phosphate groups bind two Mg2+ ions, 
the β phosphate makes interactions with the N-terminal domain side chains of His26 and 
Arg145 and the γ phosphate makes contacts with the side chains of Lys49 and His53. The 
Mg2+ ions both have octahedral coordination and are ligated by three phosphate oxygen 
atoms. One Mg2+ ion has three bound water molecules and the other Mg2+ ion binds to the 
side chains of Asp195, Asp196 and one water to complete the coordination shell. 
Pimelic acid binds in an elongated tunnel (Supplementary Fig. 5d and 5e) and the 
carboxylate group at the C7 (ω) position, that does not react with ATP is anchored in both 
structures by a salt bridge to Arg213, as well as forming hydrogen bonds to two tyrosine side-
chains (Tyr199 and Tyr211, Figs. 2e  and Supplementary Fig. 5d). There are some small 
differences in the precise conformation of the alkyl chains between the two structures that 
arise from the different location of the reactive carboxylate (C1, α) in the two subunits. 
Despite this, in both structures the alkyl chain makes contacts (< 4.0 Å) along its length with 
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the enzyme such that any substitution of hydrogens with larger heteroatoms would result in 
clashes.  
A crystal of the enzyme with CoASH and pimelic acid has density for two pimelic acid 
molecules but only one CoASH (Fig. 2f and Supplementary Fig. 5f and 5g). There is 
however no reliable density for the pantetheine arm (only the adenine, ribose and three 
phosphates clearly defined). CoASH is bound close to the dimer interface where it interacts 
with the strands of the N-terminal domain. The adenine ring makes a hydrogen bond to Glu66 
from the other subunit, whilst the 3-phosphate is bound by a cluster of three Arg residues 
(Arg13, Arg123, Arg145). A surface plot (Supplementary Fig. 5h) of the complex reveals 
two possible tunnels that reach from the CoASH binding sites to the pimelic acid. One tunnel 
is formed by residues Arg11, Arg13, Glu31, Arg123 and Arg145, whilst the other is formed 
by His26, Arg55, Asp195. Although the ordered pyrophosphate group of CoASH points 
towards the first of these tunnels, the disorder of the pantothenate arm and the fact that the 
complex was obtained by soaking (thus restricting any conformational change) precludes a 
definitive assignment of the correct tunnel. The 5-pyrophosphate group does not make any 
hydrogen bonds. We suggest that due to the two fold non-crystallographic axis, were a 
second molecule of CoASH to be bound, the terminal 5′ phosphates of the CoASH would be 
closer than 4.0 Å. 
 
Native mass spectrometry analysis of BioW 
We used native ESI-MS analysis to detect BioW-bound intermediates 34 and observed charge 
state distributions consistent with monomeric and dimeric protein (Fig. 3a). Deconvolution of 
the +14 charge state is consistent with the mass of the ligand-free BioW dimer (Fig 3a,b, 
observed m/z = 4233.9, theoretical m/z = 4233.6).  
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Upon addition of pimelic acid and MgATP, we observed two species, a dominant mass of m/z 
= 4304.0 consistent with the formation of a BioW dimer: pimeloyl-adenylate complex with 
2:2 stoichiometry (mass difference 980.7 Da, Fig. 3c) and a smaller peak corresponding to a 
single pimeloyl-adenylate bound to the dimer (m/z = 4268.9). When BioW was mixed with 
pimelic acid, MgATP and CoASH we observed an increase in the relative abundance of the 
BioW dimer with only one pimeloyl-adenylate bound (m/z = 4269.0) and also of the ligand-
free BioW (m/z = 4234.4) (Fig. 3d). We only observed ions consistent with the binding of the 
pimeloyl-adenylate and failed to detect BioW complexes with either pimelic acid, MgATP, 
PP i or the product pimeloy-CoA bound. This suggested that the BioW: pimeloyl-adenylate 
intermediate complex is highly stable and is broken down in the presence of CoASH. 
 
Residues controlling substrate binding and catalysis 
Structural data and multiple sequence alignment of BioW isoforms (Supplementary Fig. 6) 
guided the selection of four residues for mutagenesis (Tyr199, Tyr211, Arg213, Arg227). 
Each BioW mutant was expressed and purified in a similar manner to the wild type enzyme. 
We measured enzyme activity (turnover) using the PP i release-based coupled assay with 
saturating concentrations of the acid, MgATP and CoASH and set the wild-type BioW 
activity (k cat,  s-1) as 100%. Mutants R227E and R227K showed reduced BioW turnover with 
the natural substrate pimelic acid by around 20 fold (~4% activity remaining) (Fig. 4a). The 
R213A mutation reduced BioW activity >99% compared with wild type and was effectively 
inactive. In contrast, mutant Y199F retained 55% activity and similarly, mutant Y211F 
retained 36% activity (Fig. 4a). 
The wild type BioW displays high specificity for pimelic acid with much reduced turnover 
observed (k cat  value ≤1%) with both shorter and longer dicarboxylic acids substrates (3, 4, 5 
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and 6, Fig. 1b, Fig. 4b, Supplementary Table 2). Both Y199F and Y211F mutants 
displayed reduced or barely detectable turnover compared to the WT BioW with shorter 
chain length substrates glutaric acid and adipic acid (Fig. 4b). In contrast, these mutants 
displayed increased activity relative to wild type BioW with the longer dicarboxylic acid 
substrates suberic acid and azelaic acid (Fig. 4b). Using an increased enzyme concentration 
of 3.0 µM we observed that the Y199F mutant displayed a two-fold improved activity with 
but no improvement with azelaic acid over wild type (Supplementary Fig. 7). In contrast, 
the Y211F mutant displayed ~4 fold increased activity with the suberic acid substrate and ~3 
fold increased activity with the azelaic acid substrate relative to the wild-type BioW 
(Supplementary Fig. 7).  
The BioW crystal structure with CoASH bound (albeit without clear density for the 
phosphopantetheine arm) identified the side-chains of Arg11 and Arg13 as potentially 
involved in binding the phosphate groups of this substrate and we generated mutants at these 
two sites (R11A and R13A). Both mutants were essentially inactive with pimelic acid 
(Supplementary Fig. 8, <1.0 % activity compared with WT).  
 
An engineered BioW displays novel activity 
The wild-type BioW enzyme displayed little activity when incubated with heptanoic acid and 
octanoic acid at both low (0.1 µM) and high (3.0 µM) enzyme concentrations respectively 
(Fig. 4b and Supplementary Fig. 7). Similarly, the Y199F mutant was also inactive with 
heptanoic acid and octanoic acid (Fig. 4b and Supplementary Fig. 7). In contrast, the Y211F 
displayed activity with both monocarboxylic acid substrates at 0.1 µM concentration (Fig. 
4b) and at the higher concentration (3.0 µM) the Y211F mutant displayed a k cat  of 0.012 ± 
0.001 s-1 and 0.008 s-1 with heptanoic acid and octanoic acid respectively (Supplementary 
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Fig. 7) Indeed, turnover was such that we could determine the Km for heptanoic (529.0 ± 79.7 
µM) and ATP (479.4 ± 81.5 µM) (Supplementary Fig. 9). We set up “synthetic reactions” 
by incubation of the wild type and the Y211F mutant enzyme (5.0 µM) with saturating 
concentrations of heptanoic acid, MgATP and CoASH for 5 hours at 30 oC. HPLC analysis 
showed that the wild type BioW produced no detectable product (Fig. 5a). In contrast, the 
BioW Y211F mutant generated a peak eluting at 20.3 minutes (Fig. 5a) which was confirmed 
as the heptanoyl-CoA (9) thioester product using mass spectrometry (Fig. 5b, predicted mass 
for C28H48N7O17P 3S [M+H]+ = 880.2113 Da, observed mass = 880.2124 Da). It is worth 
noting that despite producing no detectable product with pimelic acid, we found that the 
BioW R213A mutant did give rise to detectable amounts of the heptanoyl-CoA and octanoyl-
CoA (10) (Supplementary Fig. 7).  
Since the BioW Y211F mutant displayed novel heptanoyl-CoA synthetase activity we tested 
whether it could also accept fatty acid substrates substituted at the reduced end of the acyl 
chain. Five commercially available derivatives (7-bromoheptanoic acid, 11; 7-
aminoheptanoic acid, 12; 6-methylheptanoic acid, 13; 7-phenylheptanoic acid, 14 and 7-
octenoic acid, 15) were screened using a convenient LC-MS method to detect the formation 
of the corresponding acyl-CoA products (Supplementary Figs. 10 a-f). We observed product 
formation for all of the substrates apart from the 7-aminoheptanoic acid derivative confirming 
the broadened synthetic utility of the BioW Y211F mutant.  
 
DISCUSSION 
An early step in biotin biosynthesis requires the AONS-catalysed condensation of L-alanine 
and a thioester activated form of pimelic acid (either pimeloyl-CoA or pimeloyl-acyl carrier 
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protein (ACP), Fig. 1a). We found that BioW is highly specific for pimelic acid, turning over 
this substrate at least 100 times faster than either adipic acid or suberic acid.  
The fatty acid specificity of BioW is controlled by a cluster of residues that bind to and fix 
the position of the ω- carboxylate of pimelic acid while the carbon chain sits in a hydrophobic 
tunnel (Fig. 2e  and Supplementary Fig. 5d and 5e). Only when the intervening seven 
carbon atoms adopt an extended conformation will the other (α) carboxylate group be 
appropriately positioned to attack the α-phosphate of ATP required to generate the pimeloyl-
adenylate. Since the tunnel is restricted in volume and the ω position fixed, additional 
carbons will result in clashes with ATP and shorter chains will not reach it. We identified this 
internal ruler as the origin of the chain length selectivity of BioW. 
Superposition of the ligand-bound BioW structures revealed that the geometry of the 
incoming nucleophilic oxygen atom of the carboxylate and the phosphate is ideal for addition 
to form the pentavalent phosphorus transition state (Fig. 2d). We suggest Arg227 and Arg170 
stabilise the negative charge on the oxygen atom of the carboxylate enhancing its 
nucleophilicity. In the AMP-PNP analog structure, we identified two Mg2+ ions that will 
bridge the α and γ phosphates of ATP and in doing so each Mg2+ binds to and stabilises the 
terminal oxygen atom of the α phosphate in the transition state. In the BioW:pimeloyl-
adenylate:PP i complex the two Mg2+ ions bind to and, we presume, stabilise the negatively 
charged PP i leaving group.  
We found that PPi release (and thus activity in our coupled assay) only occurs in a substantial 
amount when CoASH is bound to the enzyme (Supplementary Fig. 9). Mutation of 
predicted CoASH binding residues (Arg11, Arg13) stopped turnover even in the presence of 
CoASH (Supplementary Fig. 9). Such a tight coupling would be desirable in vivo since 
futile consumption of ATP would be deleterious to the cell. Since ATP and pimelic acid bind 
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to the protein in the absence of CoASH, these data suggested either the adenylate does not 
form in the absence of CoASH or that the adenylate is stable until CoASH binds. We favour 
the latter explanation as, in the absence of CoASH, we observed the adenylate intermediate in 
crystals (Fig. 2c) and by native mass spectrometry (Fig. 3). Adenylates are usually highly 
reactive, as exemplified in studies of biotin protein ligase (BPL), which generates the biotin-
adenylate intermediate that is used to transfer biotin onto the biotin carrier domain of ACC. 
Mutation of a key arginine in BPL releases the adenylate intermediate, allowing it to 
biotinylate in a promiscuous manner 35, 36, and this has been used in biotin proximity assays 
(named BioID) 37. The BioW assay had a detectable background rate without CoASH 
suggesting water can hydrolyse the adenylate (Supplementary Fig. 9). The adenylate 
intermediate, although bound in the enzyme, is not shielded from solvent with water 
molecules positioned close to the carboxylate group (Fig. 2e). We suggest that the 
positioning and hydrogen bonding of the water molecules means they cannot rapidly 
hydrolyse the adenylate and this accounted for the very unusual stability of the adenylate 
intermediate. 
In a crystal soaked with CoASH, all but the pantothenate arm was located experimentally and 
mutagenesis at the ribose phosphate binding site supported our assignment that this is where 
CoASH binds (Fig. 2f). BioW possesses two possible tunnels from the surface to the catalytic 
site that could be consistent with the pantothenate arm reaching in to attack the adenylate 
(Fig. 6 and Supplementary Fig. 5h). To form the thioester bond, the thiol group must 
displace at least one water molecule at the adenylate and since thiols are generally regarded 
as stronger nucleophiles than water, we suggest the thiol is sufficiently reactive to decompose 
the adenylate in the presence of Arg227. It has been proposed that class I-III ANL enzymes 
undergo large conformational changes during their catalytic cycle, the C-terminal domain 
rotates in relation to the N-terminus in the presence of CoASH 25, 38. We did not observe any 
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such large conformational changes in the class IV BioW, but we cannot exclude such a 
mechanism. 
Thioesters are chemically synthesised in an analogous way to the enzymatic process; 
typically by acid activation (e.g. as acid anhydrides or acid chlorides), then reaction with an 
appropriate thiol. Older methods are low-yielding and the di-acids have to be protected to 
direct synthesis of mono-thioester targets. Alternative methods such as iron-catalysed 
coupling of aldehydes with sulfur surrogates 39 and methyl acyl phosphates have been 
developed 40, but a “green” biocatalytic synthesis of simple fatty acid thioesters would be 
highly desirable. The relatively simple catalytic domain of BioW provided an ideal template 
to engineer an enzyme with expanded substrate range. Having defined the chain length 
specificity and the “internal ruler” (Fig. 2e), we made mutants at Tyr199 and Tyr211 that 
trimmed back H-bond donors and side chains that mediate electrostatic interactions. We 
found that the BioW Y211F mutant retained activity with pimelic acid and gained the ability 
to synthesise heptanoyl-CoA from heptanoic acid (Fig. 5). We saw no evidence that the 
adenylate intermediate is released into solution suggesting that the mutant enzyme has 
retained the ability to stabilise the non-cognate adenylate intermediate.  
Encouraged by the gain of function of BioW Y211F, we tested a variety of fatty acid 
derivatives modified at the terminus of the acyl chain and found that the enzyme was able to 
convert four of the five substrate analogues into the corresponding acyl-CoA thioester 
product (Supplementary Fig. 10). This result exemplified the synthetic utility of a BioW 
mutant to generate useful acyl-CoA products. A promiscuous acyl-ACP synthetase (AasS) 
from Vibrio harveyi has also been used to attach various fatty acid substrates to ACPs 41. 
With its expanded substrate range, our BioW Y211F mutant is a useful addition to the toolkit 
that enables enzyme-catalysed preparation of these useful chemical building blocks. BioW is 
a relatively small enzyme, with few residues defining the active site, so we propose that this 
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new member of the ANL superfamily (the first class IV member) offers great scope to 
expand the range of acyl-thioesters that can be synthesised. Exemplifying this idea, the BioW 
R213A mutant accepted octanoic acid, suggesting that the active site can be further exploited 
and engineered to accept longer acyl chains. Applying the tools of directed evolution and 
combining these with the application of a high-throughput assay for acyl-CoA thioester 
formation activity would allow the full synthetic potential of BioW to be explored 42. 
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Figure Legends 
 
Figure 1. The BioW reaction highlighting its role in biotin biosynthesis and the activity 
of wild type BioW with various fatty acid substrates. (A) The enzyme pimeloyl-CoA 
synthetase (BioW) catalyses the conversion of pimelic acid to the pimeloyl-CoA thioester via 
the pimeloyl-adenylate intermediate. In the next step the condensation of pimeloyl-CoA with 
L-alanine is catalysed by the pyridoxal 5’-phosphate (PLP)-dependent enzyme 8-amino-7-
oxononanoate synthase (AONS). The product of this reaction, 8-amino-7-oxononanoate, is 
then converted to 7,8-diaminononanoate (DAN) by the PLP-dependent transaminase 
diaminononanoate synthase (DANS). The ureido ring of dethiobiotin is formed by the 
enzyme dethiobiotin synthease (DTBS). The final step involves the insertion of sulfur and is 
catalysed by the enzyme biotin synthase (BS). AMP is adenosine monophosphate. (B) The 
PPi release assay was used to determine enzyme activity and is based on turnover (k cat , s-1) in 
the presence of BioW (0.1 µM), ATP (1.0 mM) and CoASH (1.0 mM) and carboxylic acids 
(1.5 mM) of various carbon chain lengths. The best BioW substrate is pimelic acid (C7; 1) 
and the worst is azelaic acid (C9; 6). Data represent mean values ± s.d. from multiple 
experiments. 
 
Figure 2. Structural biology of BioW. (A) Overall structure of the BioW dimer. The AMP-
PNP and pimelic acid molecules are shown as sticks (carbon in yellow, oxygen in red, 
nitrogen in blue and phosphate in orange). The protein A and B subunits are colored green 
and blue, respectively. The N-terminal domain is highlighted by a dashed box. 
(B) Overall structure of BioW monomer. Secondary structure elements are labelled and 
coloured red (α-helices), yellow (β-sheets) and green (loops). AMP-PNP and pimelic acid are 
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shown as sticks (carbon atoms in white, other atoms as in (a)), and Mg2+ ions are shown as 
green spheres. 
(C) Fo-Fc electron density omit map at 3 σ around the pimeloyl-adenylate. Compounds are 
shown as sticks with carbon atoms colored cyan, other atoms as (a). 
(D) Superposition of the pimeloyl-adenylate / PPi and AMP-PNP / pimelic acid complexes. 
For clarity, the protein has been removed. Carbon atoms are coloured in cyan (pimeloyl-
adenylate) and yellow (AMP-PNP/pimelic acid), other atoms as (a). The superposition allows 
a model for the pentavalent phosphorous transition state to be deduced. 
(E) The pimeloyl-adenylate is stable, despite two water molecules (W1 and W2) being 
positioned close to the adenylate ester carbonyl group. The hydrogen bonding network and 
positioning of waters inhibits their ability to attack the ester. 
(F) Binding site of the adenosine 3', 5'-diphosphate group of CoA. Residues within 4.0 Å of 
the CoA are displayed. Carbon atoms of the CoA are pink and residues of A and B subunits 
are light cyan and white. 
 
Figure 3. Native mass spectrometry analysis of BioW. (A) BioW is observed as a 
monomer (charge states 12+ to 9+) and a dimer (charge states 16+ to 13+) by native mass 
spectrometry when ionised from 200 mM ammonium bicarbonate buffer. The 14+ charge 
state dimer species [boxed in (A) and expanded in (B)], has observed m/z = 4233.9 and is in 
good agreement with the theoretical m/z = 4233.6. (C) Incubation of BioW with 1.0 mM 
pimelic acid and 1.0 mM MgATP led to the formation of a 14+ ion with m/z = 4304.0. This 
mass difference (980.7 Da) is consistent with non-covalent binding of two molecules of 
pimeloyl-adenylate (theoretical mass 489.4 Da). (D) Addition of 0.5 mM CoASH to the 
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incubation described in (C) led to an increase in the intensity of the ion with m/z = 4269.0 
which is consistent with one molecule of pimeloyl-adenylate. 
 
Figure 4. Activity of wild type BioW and active site mutants towards pimelic acid and 
assays to determine the chain length specificity of BioW and designed mutants. (A) The 
pyrophosphate (PPi) release assay was used to determine enzyme activity and is based on 
turnover (k cat , s-1) in the presence of BioW enzyme (0.1 µM, WT and mutant), pimelic acid 
(1.5 mM), ATP (1.0 mM), CoASH (1.0 mM). The value for WT BioW (0.48 s-1) was set at 
100% and the BioW mutant values are shown relative to WT. (B) The turnover (k cat , s-1) of 
the BioW WT enzyme and each of the mutants Y199F, Y211F and R213A (0.1 µM) in the 
presence of different mono- and dicarboxylic acids (compounds 3, 4, 5, 6, 7, 8, 1.5 mM), 
ATP (1.0 mM) and CoASH (1.0 mM). The WT BioW data with pimelic acid (0.48 s-1) is 
included for comparison. Data represent mean values ± s.d. from multiple experiments. 
 
Figure 5. Synthesis of hepatonyl-CoA by the engineered BioW Y211F mutant. The WT 
BioW enzyme and Y211F mutant were incubated with the heptanoic acid, ATP and CoASH 
substrates for 5 hours at 30 oC before analysis by HPLC. The heptanoyl-CoA product elutes 
at 20.3 minutes. No detectable product is observed using the WT BioW. (B) The peak eluting 
at 20.3 minutes was collected and confirmed as C7-CoA by FT-ICR Mass spectrometry 
(predicted mass for C28H48N7O17P 3S [M+H]+ = 880.2113 Da, observed 880.2124 Da). The 
expertimental mass spectrum shown (m/z range = 878-886) matches that predicted (the red 
dots are the isotope distribution based on the chemical formula) and the inset is the full mass 
spectrum (m/z range = 0-2500). 
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Figure 6. Schematic of the BioW active site . The key residues in the C-terminal domain 
involved in pimelic acid recognition (Tyr199, Tyr211 and Arg213) are highlighted, as are 
those involved in pimeloyl-adenylate binding (Arg170, Arg227). The N-terminal residues 
involved in coenzyme A (CoASH) binding (Arg11 and Arg13) are included, as is the PPi 
derived from ATP and the coordinating Mg2+ ions. We propose formation of the pimeloyl-
CoA thioester product by attack of the adenylate intermediate by the thiol of the incoming 
CoASH. 
 
ONLINE METHODS 
Reagents 
Standard chemical reagents (pimelic acid or other dicarboxylic acids, mono- fatty acids, ATP, 
buffers) and enzymes were from Sigma, Alfa Aesar and Acros Organic. CoASH was from 
Chem-Impex International. UV-transparent plates were from Costar.  
 
Cloning, expression and purification 
The full-length, codon-optimised bioW gene (Bacillus subtilis (strain 168), UNIPROT code: 
P53559) was purchased from GenScript and cloned into two expression plasmids to give 
recombinant BioW with a non-cleavable N-terminal 6His tag (pET-28a) and a pEHISTEV 
plasmid which gives an N-terminal tobacco etch virus (TEV) protease-cleavable His6 tag 43. 
The B. subtilis bioW gene was expressed in E. coli BL21 (DE3) transformed with the 
appropriate plasmid and 2 L LB media were grown in 500 ml shake flasks until the OD600 
reached 0.6-0.8. Expression was induced with 0.1 mM IPTG and the cells were grown at 30 
°C for 4 h. All purification steps were performed at 4 °C or on ice. Cells were resuspended in 
lysis buffer (20 mM sodium phosphate pH 7.5, 500 mM NaCl, 10 mM imidazole, 2 mM 
TCEP, 10% glycerol with the addition of complete EDTA-free protease inhibitor tablets 
(Roche), DNase (0.2 mg per 10 mL buffer) and lysozyme (1 mg per 10 mL buffer,) and lysed 
with a cell disruptor at 30 kPSI (Constant Systems Ltd). The crude lysate was cleared by 
centrifugation (45,000 g, 4 °C, 30 min), filtered through a 0.22 µm filter and loaded onto a 
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5ml His-trap (GE Healthcare) column attached to an AKTA system. The column was washed 
with the same lysis buffer without the protease inhibitor tablet and DNase. The BioW was 
eluted with an increasing imidazole gradient (25-300 mM) over 20 column volumes (100 ml). 
Eluted BioW was dialysed against 1L of 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 2 mM β-
mercaptoethanol (BME), 10% glycerol, 0.25 mM PMSF for 1h. Where appropriate (e.g. for 
crystallisation), the His6 tag was cleaved by incubation with TEV protease (mass ratio 1:15) 
overnight. The uncleaved protein and protease were then removed by passage through a 
second HisTrap column in lysis buffer containing 20 mM imidazole. Finally, the BioW 
(6His-tagged or TEV-cleaved) was loaded onto a gel filtration Superdex 200 column (GE 
Healthcare) in 10 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.25 mM PMSF, 1 mM dithiothreitol 
(DTT). After His6 tag removal, the BioW N-terminus contains the sequence GAMEEE. Each 
step of the purification was monitored by SDS-PAGE and the masses of both His6 BioW and 
TEV-cleaved BioW were confirmed by LC ESI-MS analysis. 
 
Site-directed and site-saturation mutagenesis. 
The BioW mutants Y199F, Y211F and R213A were constructed according to the overlapping 
primer site-directed mutagenesis method 44 with the following primers pairs. 
 
Y199F 
Y199F forward (5′-
ATGCTGGTCGGACGATCCGGATTTCATAACAGGCTATGTTGCGGGTAAGAAAAT
GGGCTAT-3′) 
Y199F reverse (5′-
CTTACCCGCAACATAGCCTGTTATGAAATCCGGATCGTCCGACCAGCATAATTCT
GCAACG-3′) 
 
Y211F 
Y211F forward (5′-
ATGTTGCGGGTAAGAAAATGGGCTTCCAGCGTATTACAGCAATGAAAGAATACG
GGACTG-3′) 
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Y211F reverse (5′-
CTTTCATTGCTGTAATACGCTGGAAGCCCATTTTCTTACCCGCAACATAGCCTGTT
ATG-3′) 
 
R213A 
R213A forward (5′-
GCGGGTAAGAAAATGGGCTATCAGGCAATTACAGCAATGAAAGAATACGGGAC
TGAAG-3′) 
R213A reverse (5′-
CCCGTATTCTTTCATTGCTGTAATTGCCTGATAGCCCATTTTCTTACCCGCAACAT
AG-3′). 
 
R11A 
R11A forward (5′-
GAAGAAACTTTTTATAGTGTCGCTATGAGGGCTTCAATGAATGGATCTCATGAAG
ACGGCGG-3′) 
R11A reverse (5′-
GAGATCCATTCATTGAAGCCCTCATAGCGACACTATAAAAAGTTTCTTCTTCCAT
GG-3′) 
 
R13A 
R13A forward (5′-
GAAGAAACTTTTTATAGTGTCAGAATGGCTGCTTCAATGAATGGATCTCATGAAG
ACGGCGG-3′) 
R13A reverse (5′-
GAGATCCATTCATTGAAGCAGCCATTCTGACACTATAAAAAGTTTCTTCTTCCAT
GG-3′) 
 
R227E and R227K 
The BioW mutants R227E, R227K were generated by saturation mutagenesis with the 
following primers: 
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R227X forward (5′-
ATACGGGACTGAAGAGGGCTGCRMAGTCTTTTTTATTGATGGCTCCAATGATGTA
AACA-3′) 
R227X reverse (5′-
GGAGCCATCAATAAAAAAGACTKYGCAGCCCTCTTCAGTCCCGTATTCTTTCATT
GCTG-3′) 
Where R = A/G, M = A/C, K = G/T, Y = C/T. 
Colonies were picked, sequenced and based on the results BioW mutants R227E and R227K 
were taken forward for analysis. All BioW point mutant proteins were overexpressed with 0.5 
mM IPTG at 20 °C overnight. The purification protocol is the same as the His6 tagged wild 
type protein with TEV protease removal of the His tag. The mass of each BioW mutant was 
confirmed by LC electrospray ionization mass spectrometry (ESI-MS). 
 
Enzyme assays 
Monitoring of acyl-CoA thioester bond formation. 
Measurements were made by a previously described continuous UV spectrophotometric 
assay 23. This assay is based on monitoring the formation of the acyl-CoA thioester bond at 
230 nm. The BioW enzyme (0.2 μM) in 100 mM Tris-HCl pH 8.5, 200 mM NaCl, 10 mM 
MgCl2 was incubated at 30 °C with 0.4 mM CoASH, 0.4 mM ATP in a reaction volume of 
200 μL The reactions were started by the addition of 1.5 mM pimelic acid and the 230 nm 
absorbance was recorded for 30 minutes on a BioTek Synergy HT plate reader with Costar 
96-well UV-transparent plates. The rate over the first 10 minutes was analysed using the 
Michaelis-Menten model and a nonlinear regression fit on GraphPad to give values of Km  and 
k cat . 
 
Pyrophosphate (PPi) production assay. 
The BioW activity was also determined by monitoring the release of PPi via a two enzyme 
coupled assay. The final volume of the reactions was 200 μL and contained 50 mM Tris-HCl 
pH 8.0, 100 mM NaCl, 10 mM MgCl2, 1.0 mM triscarboxyethylphosphine (TCEP), 0 to 1.0 
mM CoASH, 0 to 1.0 mM ATP, 0.5 mM 7-methyl-6-thioguanosine (MESG, Berry & 
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Associates), 0.03 U of inorganic pyrophosphatase (PPase from baker’s yeast, Sigma), 1 U of 
bacterial purine nucleoside phosphorylase (PNP, Sigma) and 0.1 μM BioW enzyme (or up to 
3.0 μM for several mutants). These reagents were pre-incubated at 30 °C for 15 min and the 
reaction was initiated by adding 0 to 1.5 mM pimelic acid (or dicarboxylic acids or fatty acid 
substrates of varying carbon chain length). The increase in absorbance at 360 nm resulting 
from the enzymatic conversion of MESG to 7-methyl-6-thioguanine (ε360= 11,000 M-1cm-1) 
was monitored over 30 min on a BioTek Synergy HT plate reader with Costar 96-well UV-
transparent plates. The data from the first 10 minutes was analysed using the Michaelis-
Menten model and a nonlinear regression fit on GraphPad gave values of Km  and k cat . 
 
High Performance Liquid Chromatography (HPLC) analysis of acyl-CoA formation. 
The formation of acyl-CoA esters was detected by an HPLC method. The reactions contained 
25 mM Tris-HCl pH 8.0, 50 mM NaCl, 5 mM MgCl2, 0.2 mM TCEP, 1.5 mM CoASH, 1.5 
mM ATP, 5.0 μM BioW and 1.5 mM mono- or dicarboxylic acid substrate (and substituted 
derivatives) were incubated at 30 °C in a final volume of 500 μL. The reactions were 
terminated at varying time points by incubation with acetonitrile (0.1% TFA, (trifluoroacetic 
acid)) (volume ratio 1:1). The samples were clarified by centrifugation at 17, 000 x g for 10 
minutes and filtered through a 0.45 μm filter. 10 to 50 μL of the sample was then injected 
onto Luna 5μ C18(2) RP-HPLC column (100A, 250x4.60mm, Phenomenex),and eluted with 
water (0.1% TFA v/v) for 5 min followed by a 15 min gradient from 5% to 55% acetonitrile 
(0.1% TFA, v/v)/water (0.1% TFA, v/v) which was maintained for 5 min, returning to 100% 
water (0.1% TFA) for the final five minutes. The eluant was monitored at 260 nm and where 
necessary the peak containing the acyl-CoA product was collected and concentrated under 
reduced pressure (to remove TFA and acetonitrile) and heating at 35 °C. Samples were either 
resuspended or diluted into further into water and analysed by FT-ICR Mass Spectrometry on 
a 12 Tesla SolariX FT-ICR MS (Bruker Daltronics) via positive electrospray ionisation. For 
MS, samples were co-injected with ESI-L Low Concentration Tuning Mix (Agilent 
Technologies, G1969-85000). Synthetic pimeloyl-CoA standard was prepared using a 
published method 45.  
 
Mass spectrometry analysis of acyl-CoA products  
2.5 μL of the BioW incubated with various fatty acids (see HPLC analysis above) was 
injected onto a Kinetex 5μm C18 reverse phase column (100Å, 50x2.1mm, Phenomenex) and 
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eluted at 0.5ml/min with buffers A (0.1% v/v formic acid) and B (acetonitrile, 0.1% v/v 
formic acid). The samples were loaded and washed with 0.5% buffer A for 5 min before 
switching from waste to MS and running a gradient from 0.5% to 55% buffer B, followed by 
column washing and equilibration. Electrospray ionisation was coupled to a Synapt G2 Q-
TOF (Waters) with a 120 °C source temperature, 2kV capillary voltage, and sampling cone 
voltage of 35. MS spectra were acquired over a 150-2000 mass range in positive polarity and 
in sensitivity mode. A lockmass correction was applied once at the beginning of each analysis 
against Leucine Enkephalin peptide. 
 
Crystallization and Structure Determination 
Crystals of BioW appeared at 4°C after a week from a hanging drop of 1 μl of protein 
solution (19 mg.ml-1, 5.0 mM pimelic acid, 1.0 mM MgCl2 and 5.0 mM ATP, AMP-PNP or 
BrATP) with 1 μl of reservoir solution containing 26 % PEG 400, 0.1 M HEPES pH 7.5 in 
vapor diffusion with reservoir. For phasing, crystals were soaked in 50 mM K2PtCl4 for 
approximately 15 minutes and back-soaked in mother liquor containing pimelic acid, ATP 
and MgCl2. Crystals crystalized in the presence of BrATP were soaked overnight in a 
crystallisation solution containing 20 mM CoASH and 5 mM pimelic acid before been flash 
frozen. BrATP was not present in the crystal structure but a residual density in the chain A 
active site has been modelled as a PEG400 molecule. Data were collected at 100 °K at the 
Diamond light source Oxfordshire, beamlines IO3 (λ=1.07206), IO4 (λ=0.97949) and IO2 
(λ=0.9795) for K2PtCl4, AMP-PNP/pimelic acid and pimelic acid/CoASH complexes 
respectively. For the Pimeloyl-adenylate/PPi complex, data were collected in house using a 
Rigaku MicromaxTM-007HF Cu anode with VariMax optics and Rigaku Saturn 944+ CCD 
detector. Data were processed with XIA2 46-50 or HKL2000 51. Phases were determined by 
SAD and an initial model built using the Crank pipeline 52 as implemented in CCP4i2 53 and 
the structure refined with REFMAC5 and adjusted with COOT 54 and Autobuild program of 
PHENIX 55. 
Subsequent structures were solved by molecular replacement with the program PHASER 56 
using the coordinates from the experimental structure. Final models were adjusted with 
COOT 54 and refinement was carried out using REFMAC in the CCP4 program suite with 
NCS restraints and TLS parameters 57. Final refinement statistics are given in Supplementary 
Table 3. Atomic coordinates and structure factors have been deposited in the Protein Data 
Bank (5fm0, 5flg, 5fll, 5g1f). Coordinates and topologies of ligands were generated by 
PRODRG 58. The quality of all structures were checked with MOLPROBITY 59. The 
29 
 
Ramachandran statistics are as followed: 98.6% favored and 1.4% allowed for K2PtCl4; 
100% favored for the AMP-PNP/pimelic acid complex; 99.2% favored and 0.8% allowed for 
the pimeloyl-adenylate/PPi complex; 98.3% favored and 1.7% allowed for the pimelic 
acid/CoASH complex. Figures were drawn using PYMOL 60.  
 
Native Mass Spectrometry 
The BioW sample was desalted twice over P6 Micro Bio-Spin columns (Bio-Rad) into 200 
mM ammonium bicarbonate and further diluted to approximately 20 µM (10 µM dimer). 
Native MS spectra were acquired before and after addition of 1.0 mM MgATP, 1.5 mM 
pimelic acid and 0.5 mM CoASH. Samples were infused by nano-electrospray ionisation 
(nano-ESI) using a TriVersa NanoMate (Advion) set at 1.6 kV and 0.8 psi pressure. 
Electrospray was coupled to a Synapt G2 Q-TOF (Waters) with the source set at 80 oC, 
backing pressure increased to 5 mbar, and sampling cone voltage of 150 V. Spectra were 
averaged over 4 minutes of acquisition data and presented without further data processing. 
Peak m/z annotations were extracted from smoothed and centroided using Waters MassLynx 
V4 software. 
 
Data Availability 
Crystallographic X-Ray crystal structures of all BioW structures reported have been 
deposited in the Protein Data Bank under accession codes: 5fm0 (BioW:K2PtCl4 soak), 5flg 
(BioW-AMP/PNP/pimelic acid), 5fl1 (BioW: pimeloyl-adenylate/PP i), 5g1f (BioW: pimelic 
acid/CoASH soak). The research data supporting this publication can be accessed at 
Datashare [http://dx.doi.org/10.7488/ds/1560]. 
 
Online Methods References 
43. Liu, H. & Naismith, J.H. A simple and efficient expression and purification system using two 
newly constructed vectors. Protein Expr Purif 63, 102-11 (2009). 
44. Liu, H. & Naismith, J.H. An efficient one-step site-directed deletion, insertion, single and 
multiple-site plasmid mutagenesis protocol. BMC Biotechnol 8, 91 (2008). 
45. Ploux, O. & Marquet, A. The 8-amino-7-oxopelargonate synthase from Bacillus sphaericus. 
Purification and preliminary characterization of the cloned enzyme overproduced in 
Escherichia coli. Biochem J 283 ( Pt 2), 327-31 (1992). 
46. Winter, G. xia2: an expert system for macromolecular crystallography data reduction. 
Journal of Applied Crystallography 43, 186-190 (2010). 
47. Zhang, Z., Sauter, N.K., van den Bedem, H., Snell, G. & Deacon, A.M. Automated diffraction 
image analysis and spot searching for high-throughput crystal screening. Journal of Applied 
Crystallography 39, 112-119 (2006). 
30 
 
48. Sauter, N.K., Grosse-Kunstleve, R.W. & Adams, P.D. Robust indexing for automatic data 
collection. Journal of Applied Crystallography 37, 399-409 (2004). 
49. Kabsch, W. Automatic Processing of Rotation Diffraction Data from Crystals of Initially 
Unknown Symmetry and Cell Constants. Journal of Applied Crystallography 26, 795-800 
(1993). 
50. Evans, P. Scaling and assessment of data quality. Acta Crystallographica Section D-Biological 
Crystallography 62, 72-82 (2006). 
51. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. 
Methods in Enzymol., Macromolecular Crystallography, Pt A 276, 307-326 (1997). 
52. Skubak, P. & Pannu, N.S. Automatic protein structure solution from weak X-ray data. Nat 
Commun 4, 2777 (2013). 
53. Winn, M.D. et al. Overview of the CCP4 suite and current developments. Acta 
Crystallographica Section D-Biological Crystallography 67, 235-242 (2011). 
54. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D 
Biol Crystallogr 60, 2126-32 (2004). 
55. Terwilliger, T.C. et al. Iterative model building, structure refinement and density 
modification with the PHENIX AutoBuild wizard. Acta Crystallogr D Biol Crystallogr 64, 61-9 
(2008). 
56. McCoy, A.J. et al. Phaser crystallographic software. Journal of Applied Crystallography 40, 
658-674 (2007). 
57. Murshudov, G.N., Vagin, A.A. & Dodson, E.J. Refinement of macromolecular structures by 
the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53, 240-55 (1997). 
58. Schuttelkopf, A.W. & van Aalten, D.M. PRODRG: a tool for high-throughput crystallography 
of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 60, 1355-63 (2004). 
59. Chen, V.B. et al. MolProbity: all-atom structure validation for macromolecular 
crystallography. Acta Crystallogr D Biol Crystallogr 66, 12-21 (2010). 
60. The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC. 
 
 
31 
 





NN
N
N
NH2
O
HO
O
P
O O-
-O
O
P-O O
O
P
O
-O O
O
HN
HO
HN
O
SH
Arg13
H
N NH2
NH2
N
H
NH2
NH2Arg11
OH
Tyr211
NHH2N
NH2
Arg213
-O
O
O
O P
O
O
O-
O
N
OH
OH
N
N
N
H2N
HO
Tyr199
NH2H2N
HN
Arg170
O-
PO
P
-O
O
O
O-
O-
Mg2+
Mg2+
H2N
NH
H2N
Arg227
PPi
pimeloyl-
adenylate
coenzyme A
Pimelic Acid
Pimeloyl-CoA
ild type BioW
AMP + PPi
ATP CoASH
Substituted fatty acids
Substituted fatty acids
AMP + PPi
ATP CoASH
Engineered
BioW Y211F
O
O
O
P
O
O-
N
NN
N
H2N
O
OH
OH
-O
O
NH2
H2N
NH
OH
HO
H2N
H2N NH
O-POP-O OO
-O-O
Tyr199
Arg213
Tyr211
Arg227
PPi
H2N
NH2
NH
Arg170
Pimeloyl-
adenylate
